These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Clinical and endocrinological aspects of 21-hydroxylase deficiency. New MI. Ann N Y Acad Sci; 1985 May; 458():1-27. PubMed ID: 3911845 [No Abstract] [Full Text] [Related]
32. Different gene defects in the salt-wasting (SW), simple virilizing (SV), and nonclassical (NC) types of congenital adrenal hyperplasia (CAH). Knorr D, Albert ED, Bidlingmaier F, Höller W, Scholz S. Ann N Y Acad Sci; 1985 May; 458():71-5. PubMed ID: 3879133 [Abstract] [Full Text] [Related]
33. MHC "supratype" predicting heterozygous 21-hydroxylase deficiency. McCluskey J, Kay PH, Stuckey M, Christiansen FT, Dawkins RL, Wilson G. Lancet; 1983 Apr 02; 1(8327):764-5. PubMed ID: 6132105 [No Abstract] [Full Text] [Related]
34. HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. White PC, New MI, Dupont B. Proc Natl Acad Sci U S A; 1984 Dec 02; 81(23):7505-9. PubMed ID: 6334310 [Abstract] [Full Text] [Related]
39. Heterozygotes and cryptic patients in families of patients with congenital adrenal hyperplasia (21-hydroxylase deficiency). HLA and glyoxalase I typing and hormonal studies. Petersen KE, Svejgaard A, Nielsen MD, Dissing J. Horm Res; 1982 Dec 02; 16(3):151-9. PubMed ID: 6286442 [Abstract] [Full Text] [Related]